Adocia SA (ADOCY)
OTHER OTC:ADOCY
Adocia Stock Analysis & Ratings
4 Followers
ADOCY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.18 - $12.19
Previous Close$5.33
Volume0.00
Average Volume (3M)N/A
Market CapN/A
Enterprise ValueN/A
P/E RatioN/A
Beta-1.83
Next EarningsSep 19, 2022
EPS Forecast-$0.82
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart ScoreN/A
EPS (TTM)N/A
Shares Outstanding7,820,227
R-Squared0.21
Standard Deviation0.17
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
P/B Ratio-5.87
P/S Ratio92.00
P/CF Ratio51.80
P/FCF Ratio-6.60
Total Debt$0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
Alpha-0.02
Number of Analyst Covering0
P/E Ratio Range
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.
---
ADOCY FAQ
What was Adocia’s price range in the past 12 months?
Adocia lowest stock price was $4.17 and its highest was $12.19 in the past 12 months.
What is Adocia’s market cap?
Currently, no data Available
What is Adocia’s price target?
Currently, no data Available
What do analysts say about Adocia?
Not enough analysts have published a price target to provide an average price target.
When is Adocia’s upcoming earnings report date?
Adocia’s upcoming earnings report date is Sep 19, 2022 which is in 35 days.
How were Adocia’s earnings last quarter?
Currently, no data Available
Is Adocia overvalued?
According to Wall Street analysts Adocia’s price is currently Overvalued.
Does Adocia pay dividends?
Adocia does not currently pay dividends.
What is Adocia’s EPS estimate?
Adocia’s EPS estimate is -$0.82.
How many shares outstanding does Adocia have?
Adocia has 7,137,521 shares outstanding.
What happened to Adocia’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Adocia?
Currently, no hedge funds are holding shares in ADOCY
---
Adocia Stock Analysis
Smart ScoreNot Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Forecast
N/A
Currently Not Enough Data Available
Blogger Sentiment
N/A
Currently Not Enough Data Available
Hedge Fund Holdings
N/A
Currently Not Enough Data Available
Insider Transactions
N/A
Currently Not Enough Data Available
Retail Investors
N/A
Currently Not Enough Data Available
News Sentiment
N/A
Currently Not Enough Data Available
Technicals
SMA
Negative
20 days / 200 days
Momentum
-50.36%
12-Months-Change
Fundamentals
Return on Equity
N/A
Trailing 12-Months
Asset Growth
N/A
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Adocia SA
Adocia is a clinical-stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins. The firm has developed Biochaperone proprietary technological platform to enhance the effectiveness of therapeutic proteins. The company's product pipeline includes biochaprone lispro, biochaparone combo, biochaparone human glucagon etc. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.
---
---